Herbert Skip Virgin
Overview
Herbert Skip Virgin received an average of $3M in total compensation, including $625K in salary, at Vir Biotechnology from 2018 to 2021.
2021Vir BiotechnologyExecutive Vice President, Research and Chief Scientific Officer
2020Vir BiotechnologyExecutive Vice President, Research and Chief Scientific Officer
2019Vir BiotechnologyExecutive Vice President, Research and Chief Scientific Officer
2018Vir BiotechnologyExecutive Vice President, Research and Chief Scientific Officer
Source: SEC filings on April 7, 2022, April 6, 2021, and April 6, 2020.
Related executives
We found six more executives who work or worked at Vir Biotechnology.
George Scangos
Vir Biotechnology
Chief Executive Officer
Phillip Pang
Vir Biotechnology
Chief Medical Officer
Howard Horn
Vir Biotechnology
Chief Financial Officer
Ann Hanly
Vir Biotechnology
Chief Technology Officer
Steven Rice
Vir Biotechnology
Chief Administrative Officer
Michael Kamarck
Vir Biotechnology